These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 21797917)

  • 1. Histological evaluation of maxillary sinus floor augmentation with recombinant human growth and differentiation factor-5-coated β-tricalcium phosphate: results of a multicenter randomized clinical trial.
    Stavropoulos A; Becker J; Capsius B; Açil Y; Wagner W; Terheyden H
    J Clin Periodontol; 2011 Oct; 38(10):966-74. PubMed ID: 21797917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a pilot study in the Goettingen miniature pig comparing autogenous bone and rhGDF-5.
    Gruber RM; Ludwig A; Merten HA; Pippig S; Kramer FJ; Schliephake H
    Clin Oral Implants Res; 2009 Feb; 20(2):175-82. PubMed ID: 19077151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a histological and histomorphometric study in the Goettingen miniature pig.
    Gruber RM; Ludwig A; Merten HA; Achilles M; Poehling S; Schliephake H
    Clin Oral Implants Res; 2008 May; 19(5):522-9. PubMed ID: 18371105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 in a beta-tricalcium phosphate carrier into one-wall intrabony defects in dogs.
    Lee JS; Wikesjö UM; Jung UW; Choi SH; Pippig S; Siedler M; Kim CK
    J Clin Periodontol; 2010 Apr; 37(4):382-9. PubMed ID: 20447262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase IIa randomized controlled clinical and histological pilot study evaluating rhGDF-5/β-TCP for periodontal regeneration.
    Stavropoulos A; Windisch P; Gera I; Capsius B; Sculean A; Wikesjö UM
    J Clin Periodontol; 2011 Nov; 38(11):1044-54. PubMed ID: 22092476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of recombinant human growth/differentiation factor-5 (rhGDF-5) on bone regeneration around titanium dental implants in barrier membrane-protected defects: a pilot study in the mandible of beagle dogs.
    Weng D; Poehling S; Pippig S; Bell M; Richter EJ; Zuhr O; Hürzeler MB
    Int J Oral Maxillofac Implants; 2009; 24(1):31-7. PubMed ID: 19344022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimplantation of cultivated human bone cells from the posterior maxilla for sinus floor augmentation. Histological results from a randomized controlled clinical trial.
    Hermund NU; Stavropoulos A; Donatsky O; Nielsen H; Clausen C; Reibel J; Pakkenberg B; Holmstrup P
    Clin Oral Implants Res; 2012 Sep; 23(9):1031-7. PubMed ID: 22092973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized pilot study on the safety and efficacy of recombinant human growth and differentiation factor-5 coated onto β-tricalcium phosphate for sinus lift augmentation.
    Koch FP; Becker J; Terheyden H; Capsius B; Wagner W
    Clin Oral Implants Res; 2010 Nov; 21(11):1301-8. PubMed ID: 20546250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic and histometric evaluation of bovine cancellous bone and beta-tricalcium phosphate 45 months after grafting in maxillary sinus.
    Khatiblou F
    J Oral Implantol; 2011 Dec; 37(6):727-33. PubMed ID: 20942658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodontal wound healing/regeneration following the application of rhGDF-5 in a beta-TCP/PLGA carrier in critical-size supra-alveolar periodontal defects in dogs.
    Kwon DH; Bisch FC; Herold RW; Pompe C; Bastone P; Rodriguez NA; Susin C; Wikesjö UM
    J Clin Periodontol; 2010 Jul; 37(7):667-74. PubMed ID: 20492073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amount of newly formed bone in sinus grafting procedures depends on tissue depth as well as the type and residual amount of the grafted material.
    Artzi Z; Kozlovsky A; Nemcovsky CE; Weinreb M
    J Clin Periodontol; 2005 Feb; 32(2):193-9. PubMed ID: 15691351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study.
    Kurkcu M; Benlidayi ME; Cam B; Sertdemir Y
    J Oral Implantol; 2012 Sep; 38 Spec No():519-26. PubMed ID: 23072285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histomorphometric and immunohistochemical analysis of human maxillary sinus-floor augmentation using porous β-tricalcium phosphate for dental implant treatment.
    Miyamoto S; Shinmyouzu K; Miyamoto I; Takeshita K; Terada T; Takahashi T
    Clin Oral Implants Res; 2013 Aug; 24 Suppl A100():134-8. PubMed ID: 22220565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological evaluation of healing after transalveolar maxillary sinus augmentation with bioglass and autogenous bone.
    Stavropoulos A; Sima C; Sima A; Nyengaard J; Karring T; Sculean A
    Clin Oral Implants Res; 2012 Jan; 23(1):125-31. PubMed ID: 21504477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor-5: histologic observations.
    Polimeni G; Wikesjö UM; Susin C; Qahash M; Shanaman RH; Prasad HS; Rohrer MD; Hall J
    J Clin Periodontol; 2010 Aug; 37(8):759-68. PubMed ID: 20500538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation.
    Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maxillary sinus grafting with Bio-Oss or Straumann Bone Ceramic: histomorphometric results from a randomized controlled multicenter clinical trial.
    Cordaro L; Bosshardt DD; Palattella P; Rao W; Serino G; Chiapasco M
    Clin Oral Implants Res; 2008 Aug; 19(8):796-803. PubMed ID: 18705811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the effectiveness of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and platelet-rich fibrin-mixed tricalcium phosphate in rabbits.
    Kim BJ; Kwon TK; Baek HS; Hwang DS; Kim CH; Chung IK; Jeong JS; Shin SH
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):583-92. PubMed ID: 22676983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histomorphometric assessment of bone formation in sinus augmentation utilizing a combination of autogenous and hydroxyapatite/biphasic tricalcium phosphate graft materials: at 6 and 9 months in humans.
    Artzi Z; Weinreb M; Carmeli G; Lev-Dor R; Dard M; Nemcovsky CE
    Clin Oral Implants Res; 2008 Jul; 19(7):686-92. PubMed ID: 18492077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive transcrestal sinus floor elevation with deproteinized bovine bone or β-tricalcium phosphate: a multicenter, double-blind, randomized, controlled clinical trial.
    Trombelli L; Franceschetti G; Stacchi C; Minenna L; Riccardi O; Di Raimondo R; Rizzi A; Farina R
    J Clin Periodontol; 2014 Mar; 41(3):311-9. PubMed ID: 24325663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.